Stock price of gsk.

Oct 30, 2023 · The price/sales ratio is 1.99, and the price/book ratio is 5.47. These ratios suggest that the stock is trading at a reasonable price compared to its sales and book value. On October 30, 2023, GSK’s stock price experienced a significant increase of $0.73, or 4.23%.

Stock price of gsk. Things To Know About Stock price of gsk.

consent.yahoo.comWhat is the target price for GSK (GSK) stock? The latest price target for GSK ( NYSE: GSK) was reported by DZ Bank on Friday, February 11, 2022. The analyst firm set a price target for 0.00 ...Nov 30, 2023 · Get GSK plc (GSK.L) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments 18 Tem 2022 ... GSK share price · Share price calculators (GBp/USD) · Dividend ... Stock Exchange (the “NYSE”) at market open on Friday 22 July 2022. In addition ...See GSK plc (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... GSK plc (GSK) NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors trend 2W 10W ...

GSK: GSK plc - Stock Price, Quote and News - CNBC

Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year? Zacks Equity Research December 04, 2023 GSK Quick Quote GSK ACAD Quick …

GSK plc (ADR)’s stock is NA in 2023, NA in the previous five trading days and up 5.26% in the past year. Currently, GSK plc (ADR)’s price-earnings ratio is 9.5. GSK plc (ADR)’s trailing 12-month revenue is $37.2 billion with a 22.2% net profit margin. Year-over-year quarterly sales growth most recently was 4.1%. Analysts expect adjusted ...Over the last year, Glaxosmithkline share price has been traded in a range of 306.40, hitting a high of 1,609.00, and a low of 1,302.60.The latest closing stock price for GSK as of November 20, 2023 is 35.11. The all-time high GSK stock closing price was 54.70 on April 13, 2022. The GSK 52-week high stock price is 39.74, which is 13.2% above the current share price. The GSK 52-week low stock price is 33.20, which is 5.4% below the current share price.Written by Zacks Equity Research for Zacks ->. GSK (GSK) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Find the latest historical data for GSK plc American Depositary ... Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”.

Stock Price Forecast. The 18 analysts offering 12-month price forecasts for GSK plc have a median target of 39.86, with a high estimate of 62.61 and a low estimate of 30.03. The median estimate ...

For the year ending March 2023 GlaxoSmithKline Pharmaceuticals has declared an equity dividend of 320.00% amounting to Rs 32 per share. At the current share price of Rs 1689.00 this results in a ...Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.After close of trading on Monday, GSK will consolidate its share price to ensure the company's earnings per share and share price can be compared with previous periods, it has said. ($1 = 0.8377 ...GSK PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. GSK updated stock price target summary. ... Stock Price Target GSK. High $ 62.61: Median $ 39.86: Low $ 30.03 ...See GSK plc (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... GSK plc (GSK) NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors trend 2W 10W ... Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

See GSK PLC ORD GBP0.3125 stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... The 19 analysts offering 1 year price forecasts for GSK have a max estimate of — and a min estimate of —. Analyst rating. Based on 23 analysts giving stock ratings to GSK in the …Find the latest GlaxoSmithKline plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.Dividend and share price. This section contains a collection of useful tools to enable investors to analyse current and historical GSK share prices on the London and New York stock exchanges.USD. On Monday 18 July 2022 GSK consolidated its share capital. Shareholders received 4 new GSK shares of nominal value 31 1 / 4 pence each for every 5 existing GSK shares of nominal value 25 pence each held at 8.00pm UK on that date. Further information can be found here.Glaxosmithkline Pharmaceuticals stock price went up today, 16 Nov 2023, by 2.63 %. The stock closed at 1557.9 per share. The stock is currently trading at 1598.9 per share. Investors should ...The latest GSK plc (GSK) ORD GBP0.3125 share price (GSK). View recent trades and share price information for GSK plc (GSK) ORD GBP0.3125

An American Depository Receipt (ADR) is issued by a depository bank (JP Morgan in GSK’s case), and is used to represent a specific number of shares of a non-US company traded on a US stock exchange. This allows non-US companies to make their shares available outside their home markets and allows investors in the US and elsewhere to easily ...Nov 30, 2023 · Get GSK plc (GSK) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Complete GSK PLC ADR stock information by Barron's. View real-time GSK stock price and news, along with industry-best analysis.GSK PLC ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time GSK stock price.Find the latest GSK plc (GSK.L) stock quote, history, news and other vital information to help you with your stock trading and investing.Market Capitalization. $72.07 billion. P/E Ratio. 9.46. Dividend Yield. 3.78%. Price Target. $37.44. Stock Analysis Analyst Forecasts Chart Competitors Dividend Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media.GSK owned a controlling stake of 68% in the Consumer Healthcare JV. However, on Jul 18 2022, GSK de-merged its Consumer Healthcare (CHC) segment into a standalone company. The independent Consumer ...Find the latest dividend history for GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) at Nasdaq.com.USD. On Monday 18 July 2022 GSK consolidated its share capital. Shareholders received 4 new GSK shares of nominal value 31 1 / 4 pence each for every 5 existing GSK shares of nominal value 25 pence each held at 8.00pm UK on that date. Further information can be found here.GSK - GSK plc Stock quote - CNNMoney.com Markets Tech Media Success Video Markets Premarkets Dow After-Hours Market Movers Fear & Greed World Markets Investing …Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,419.40p. Gsk currently has 4,095,026,002 shares in issue. The market capitalisation of Gsk is £58,820,953,493. Gsk has a price to earnings ratio (PE ratio) of 3.93. This morning GSK …GSK plc analysts consensus, targets, ratings and recommendations | London Stock Exchange: GSK | London Stock Exchange

GSK share price. This page provides details of GSK's share price for stocks quoted on both the London and New York Stock Exchanges. By default, the page shows the London share price. To view US ADR data, click on the ADR tab below.

26 Nis 2023 ... Shares are forming a cup base with a buy point at 43.42, according to MarketSmith.com. Likewise, GSK stock closed in on a floor at its 50-day ...

For the fiscal year ending December 2023, this drug developer is expected to earn $3.90 per share, which is a change of 12.7% from the year-ago reported number. Analysts have been steadily raising ...Market Average Movement. 6.0%. 10% most volatile stocks in US Market. 15.3%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: GSK is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week. Volatility Over Time: GSK's weekly volatility (3%) has been stable over the past year.8 brokers have issued 12-month price objectives for GSK's shares. Their GSK share price targets range from GBX 1,245 to GBX 2,000. On average, they predict the company's stock price to reach GBX 1,573.64 in the next twelve months. This suggests a possible upside of 10.6% from the stock's current price.The sale price represents a 2.3% discount to Haleon's closing price of 342.85 pence on Thursday and lowers the stake of GSK, the second-largest shareholder, to 10.3%.GSK: GSK plc - Stock Price, Quote and News - CNBC GSK PLC GSK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals ... Prices and Markets > GSK Plc ...Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer ... Consensus Price Target is the stock ...2023. 56.5p. 4.0%. 2024. 59.9p. 4.3%. These numbers tell me the shares offer a forecast dividend yield of 4% at the moment. The dividend is expected to rise by about 6% next year, giving ...

Stock exchange announcements ... Detailed information on GSK's share price, including an interactive chart. Go to share price tool. Innovation stories ‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about 'Prevention is the best medicine to stop disease before it starts'Jul 19, 2022 · In the year so far, stock price of GSK has declined 8.4% against the industry’s 3.5% rise. In a separate press release, GSK announced that it has completed its share consolidation following the ... VRTX currently has a PEG ratio of 2.10. Another notable valuation metric for GSK is its P/B ratio of 4.69. Investors use the P/B ratio to look at a stock's market value versus its book value ...Instagram:https://instagram. which quarters are worth more money50 highest yielding preferred stockssolaredge technologycornerstone total return fund Shareholder information. Information and tools for shareholders including dividend calculator, share management tools, and advice on how to avoid share scams. Manage your shares. Annual General Meeting. General meeting. Annual governance meeting. Corporate sponsored nominee service. ADR Programme. short term medical insurance marylandreal brokerage stock The GlaxoSmithKline stock price gained 1.41% on the last trading day (Thursday, 30th Nov 2023), rising from $35.49 to $35.99.During the last trading day the stock fluctuated 1.14% from a day low at $35.61 to a day high of $36.01.The price has been going up and down for this period, and there has been a 4.41% gain for the last 2 weeks.GSK PLC ADR analyst estimates, including GSK earnings per share estimates and analyst recommendations. ... Stock Price Targets. High: $62.61: Median: $40.22: Low: $30.03: Average: $41.83: Current ... how much is a gold ingot worth GlaxoSmithKline plc (GSK.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock GlaxoSmithKline plc | LIQUIDNET SYSTEMS: GSK ...Stock Price Quotes › GlaxoSmithKline Pharmaceuticals Share Price ... -GSK has informed the Bombay Stock Exchange on October 11 that at the meeting of its board held on October 10, R R Bajaaj was appointed as additional independent director with effect from October 10, 2002.-GlaxoSmithkline Pharmaceuticals Ltd has informed BSE that …